EDI048
EDI048 (compound 1.16) is an orally active Cryptosporidium PI4K inhibitor for the research of cryptosporidiosis[1].
Product Specifications
CAS Number
[2767264-57-1]
UNSPSC
12352005
Target
Parasite; PI4K
Type
Reference compound
Related Pathways
Anti-infection; PI3K/Akt/mTOR
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/edi048.html
Purity
99.86
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(N(C)C(C2=CC3=C(C4=CC=C(C(NC)=O)C=C4)C=NN3C=C2)=O)=CC=C1Cl)OC
Molecular Formula
C25H21ClN4O4
Molecular Weight
476.91
References & Citations
[1]Joseph Michael Young, et al. Compounds and compositions for the treatment of cryptosporidiosis. Patent US20220112189A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal GATA-3 Antibody (OTI8H4) [Alexa Fluor 350]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
128228-FITC 100 µL
IFI27 (Interferon alpha-inducible Protein 27, Mitochondrial, p27, Interferon alpha-induced 11.5kD Protein, Interferon-stimulated Gene 12a Protein, ISG12 (a) ) (FITC)
Ask
View Details